STAA vs. EYE, WRBY, RXST, BLCO, GLPG, AZTA, PRVA, ITGR, ENOV, and IMVT
Should you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include National Vision (EYE), Warby Parker (WRBY), RxSight (RXST), Bausch + Lomb (BLCO), Galapagos (GLPG), Azenta (AZTA), Privia Health Group (PRVA), Integer (ITGR), Enovis (ENOV), and Immunovant (IMVT). These companies are all part of the "medical" sector.
STAAR Surgical vs.
STAAR Surgical (NASDAQ:STAA) and National Vision (NASDAQ:EYE) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings, community ranking and institutional ownership.
STAAR Surgical has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500.
In the previous week, National Vision had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 6 mentions for National Vision and 4 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 1.09 beat National Vision's score of 0.33 indicating that STAAR Surgical is being referred to more favorably in the media.
STAAR Surgical has a net margin of 10.81% compared to National Vision's net margin of 1.48%. STAAR Surgical's return on equity of 9.85% beat National Vision's return on equity.
STAAR Surgical currently has a consensus target price of $81.18, suggesting a potential upside of 40.70%. National Vision has a consensus target price of $30.33, suggesting a potential upside of 16.80%. Given STAAR Surgical's stronger consensus rating and higher possible upside, analysts plainly believe STAAR Surgical is more favorable than National Vision.
97.6% of STAAR Surgical shares are owned by institutional investors. 1.1% of STAAR Surgical shares are owned by insiders. Comparatively, 2.1% of National Vision shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
STAAR Surgical received 22 more outperform votes than National Vision when rated by MarketBeat users. However, 67.65% of users gave National Vision an outperform vote while only 58.64% of users gave STAAR Surgical an outperform vote.
National Vision has higher revenue and earnings than STAAR Surgical. National Vision is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.
Summary
STAAR Surgical beats National Vision on 12 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
STAAR Surgical Competitors List
Related Companies and Tools